Nykode Therapeutics Stock
Stocks
VACC
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.075 NOK | -2.07% |
|
-5.24% | +27.49% |
| 05-27 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-27 | Nykode Therapeutics AS, Q1 2026 Earnings Call, May 27, 2026 |
| Market Cap | 1.03B 104M 91.17M 83.78M 78.1M 148M 9.93B 150M 1.01B 391M 4.88B 391M 383M 16.82B | P/E 2026 * |
-4.86x | P/E 2027 * | -33.9x |
|---|---|---|---|---|---|
| Enterprise Value | 540M 54.95M 48.04M 44.14M 41.15M 78.05M 5.23B 79.23M 530M 206M 2.57B 206M 202M 8.86B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 2.77x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 day | -2.07% | ||
| 1 week | -5.24% | ||
| Current month | -4.50% | ||
| 1 month | -5.96% | ||
| 3 months | -5.24% | ||
| 6 months | +35.82% | ||
| Current year | +27.49% |
| 1 week | 3.06 |  | 3.29 |
| 1 month | 3.06 | | 3.4 |
| Current year | 2.21 | | 4.1 |
| 1 year | 1.44 | | 4.1 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 01/01/2019 |
| President | 49 | 01/01/2017 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 03/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 23/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/03/25 | Buy | Company | 3,000,000 | 0.9187% | ||
| 20/12/24 | Buy | Director | 100,000 | 0.0306% | ||
| 20/12/24 | Sell | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.07% | -5.24% | +66.58% | -88.41% | 104M | |
| +0.68% | +5.92% | +80.45% | +137.78% | 58.73B | |
| +2.32% | +5.89% | +76.81% | +99.20% | 53.92B | |
| -10.61% | +8.38% | -9.90% | -9.62% | 24.67B | |
| -0.30% | +6.82% | +13.60% | +428.91% | 24.19B | |
| +4.74% | +13.47% | +46.43% | +0.03% | 18.8B | |
| -0.29% | +9.78% | +44.62% | -27.94% | 17.61B | |
| 0.00% | +16.74% | +171.12% | +355.99% | 16.25B | |
| +3.50% | +4.92% | +26.07% | +192.26% | 14.04B | |
| +6.72% | +20.94% | +51.67% | - | 13.9B | |
| Average | +2.38% | +6.20% | +56.75% | +120.91% | 24.22B | |
| Weighted average by Cap. | +2.44% | +5.52% | +59.79% | +138.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 16.45M 14.38M 13.21M 12.32M 23.36M 1.57B 23.71M 159M 61.66M 770M 61.73M 60.41M 2.65B |
| Net income | -208M -21.15M -18.49M -16.99M -15.83M -30.03M -2.01B -30.49M -204M -79.28M -990M -79.37M -77.67M -3.41B | -41.58M -4.23M -3.7M -3.4M -3.17M -6.01M -403M -6.1M -40.79M -15.86M -198M -15.87M -15.53M -682M |
| Net Debt | -485M -49.34M -43.13M -39.64M -36.95M -70.08M -4.7B -71.14M -476M -185M -2.31B -185M -181M -7.96B | -578M -58.74M -51.35M -47.19M -43.99M -83.43M -5.59B -84.69M -567M -220M -2.75B -220M -216M -9.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | NOK 3.075 | -2.07% | 115,101 |
| 02/07/26 | NOK 3.140 | +1.95% | 311,061 |
| 01/07/26 | NOK 3.080 | -4.35% | 534,664 |
| 30/06/26 | NOK 3.220 | +1.10% | 132,394 |
| 29/06/26 | NOK 3.185 | -1.85% | 495,709 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VACC Stock
Select your edition
All financial news and data tailored to specific country editions
